Let’s Celebrate!

This presentation will take you through the academic year of celebrations we plan and host at the Law Library, such as Valentine’s Day, ALA’s International Games Week, Dictionary Day, and Constitution Day. By recognizing and celebrating both major and minor holidays, we boost morale, build community, expose our students to new information, and give our patrons something to look forward to. Details on purpose, time commitment, advertising, cost, engagement level, and lessons learned will be shared

Welcoming Wellness to Your Library

Promoting wellness in the library is a natural extension of our roles as librarians and the role of the library in the community. Librarians have an opportunity to be role models and to exhibit the importance of making time for daily healthy habits. In this presentation, we will discuss the ways in which we have included wellness programming at an academic law library, our successes and failures, and the impact this programming has had on our law school community. Examples of our wellness programming include yoga in the library; circulating recreational equipment; magazine subscriptions; sound baths; virtual reality; jigsaw puzzles; exam period “stressbusters” like coloring pages, word searches, and games; mindfulness sessions; and therapy dogs. For each event, we will share photos and discuss time commitment, advertising, cost, engagement level, and lessons learned

Let\u27s Celebrate!

This presentation will take you through the academic year of celebrations we plan and host at the Law Library, such as Valentine’s Day, ALA’s International Games Week, Dictionary Day, and Constitution Day. By recognizing and celebrating both major and minor holidays, we boost morale, build community, expose our students to new information, and give our patrons something to look forward to. Details on purpose, time commitment, advertising, cost, engagement level, and lessons learned will be shared

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Aims The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM). Methods and results ASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium ≥6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction). Conclusion This pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without D

Epidemiology of Osteosarcoma : Single Center Study in Indonesia

Objective- To assess osteosarcoma epidemiology in Haji Adam Malik General Hospital. Material and Methods- This study is a retrospective descriptive study with a crosssectional approach. Patient with musculoskeletal tumour (especially osteosarcoma) in Haji Adam Malik Hospital from January 2012 to Desember 2017 period, got their age, gender, musculoskeletal tumour type, biopsy result, tumour sites, treatment completion, metastasis and amputation status recorded from their medical record. Result-Primary bone tumors is the most cases and found in 50% of musculoskeletal tumors followed by soft tissue tumors and metastatic bone disease. Male (60%) have slightly higher prevalence than female in (40%). The incidence of primary bone tumors shows osteosarcoma, GCT, and osteochondroma are in the top three with 63%, 13%, and 6% respectively. Specifically for osteosarcoma, male and female have 1.9 : 1 prevalence ratio. The most common sites for osteosarcoma is distal the femur (45%) and proximal tibia (29%). About 63% of patients undergo complete treatment and with 55% recorded with metastasis in the first diagnosis and amputation was performed in 89% of patients. Conclusion- Primary bone tumors dominate the data with 50% for musculoskeletal tumors followed by 31% soft tissue tumors and 19% metastatic bone disease. The incidence of musculoskeletal tumors shows that men are slightly higher than women in 60% and 40%. The incidence of primary bone tumors shows osteosarcoma, giant cell tumor, and osteochondroma are in the top three with 63%, 13%, and 6% respectively.</jats:p

Putting the Life Back Into the Old Book: A Crash Course in Running Your Own Book Repair Clinic

UGA Law Library has had versions of a book repair clinic come and go over the years. This valuable service to the students, faculty and staff has changed formats throughout time but remains a popular program each semester. Librarians and staff work together each year to make basic repairs to textbooks and other items that are brought to the clinic. In this session our Student Services Librarian will share the scheduling and promotion of these events, and the value that is has provided to students, faculty and staff. Our Collection Services Manager and Special Collections Librarian will also talk about the how-to aspect of the clinic. They will share their backgrounds in book repair, their involvement in past and recent book repair clinic events, and the tools and other resources needed to host your own clinic. A demo of the quick and dirty types of repairs we provide for this programming will be given as well so attendees can see this work in action! Although we are an academic library, this type of program could be implemented in any library to benefit patrons who have well-loved books that need repairing